Edition:
United Kingdom

Sensus Healthcare Inc (SRTS.OQ)

SRTS.OQ on NASDAQ Stock Exchange Capital Market

5.22USD
22 Jan 2018
Change (% chg)

-- (--)
Prev Close
$5.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,000
52-wk High
$6.05
52-wk Low
$3.52

Chart for

About

Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The... (more)

Overall

Beta: --
Market Cap(Mil.): $71.36
Shares Outstanding(Mil.): 13.49
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 148.75 16.61
EPS (TTM): -- -- --
ROI: -- 9.42 10.60
ROE: -- 14.80 14.19

BRIEF-Sensus Healthcare files for mixed shelf of up to $20 mln - SEC filing

* Sensus Healthcare Inc files for mixed shelf of up to $20 million - SEC filing Source text: (http://bit.ly/2j7hKwL) Further company coverage:

06 Nov 2017

BRIEF-Sensus Healthcare reports Q3 loss per share of $0.07

* Sensus Healthcare reports third quarter financial results featuring revenue up 44 percent

02 Nov 2017

BRIEF-Sensus Healthcare launches SRT-100 in China for Keloid treatment

* Sensus Healthcare Inc - ‍has launched SRT-100 in China for treatment and prevention of Keloids with Chindex Medical Limited​

01 Nov 2017

BRIEF-Sensus Healthcare says SRT-100 now cleared for sale in Mexico​

* Sensus Healthcare Inc - ‍announces that SRT-100 is now cleared for sale in Mexico​

31 Oct 2017

BRIEF-Stratpharma AG & Sensus Healthcare announce strategic collaboration

* Stratpharma AG & Sensus Healthcare announce strategic collaboration for transformative superficial radiation therapy & post-treatment care Source text for Eikon: Further company coverage:

23 Oct 2017

BRIEF-Sensus Healthcare Q2 loss per share $0.06

* Sensus Healthcare reports record second quarter financial results

03 Aug 2017

Earnings vs. Estimates